Effect of Deutetrabenazine on Chorea Among Patients With Huntington DiseaseJane Kerr, Marie Saint‐Hilaire, Ramon L. Rodriguez et al.|JAMA|2016Cited by 397
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical TrialSamuel Frank, Richard Dubinsky, Joohi Jimenez‐Shahed et al.|Publisher|2016Cited by 44
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical TrialMichael Brownstein, Stephanie Lowenhaupt, Elaine Sperin et al.|Journal of Clinical Medicine|2020Cited by 32
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension StudySamuel Frank, Brad A. Racette, Stephanie Leyva et al.|CNS Drugs|2022Cited by 31